Summary
These modifications may provide a new strategy for early treatment of Alzheimer’s disease.
Further research is required to confirm safety and effectiveness.
Bacillus Calmette‑Guérin vaccine is designed to protect against tuberculosis.
It influences the immune system within the central nervous system.
Potentially, it could be repurposed to intervene early in Alzheimer’s disease progression.
Clinical trials will be needed to test this approach in people.
These modifications may provide a new strategy for early treatment of Alzheimer’s disease.
Further research is required to confirm safety and effectiveness.
Want to learn even more? Click here to read the full story!